Minjung Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Minjung Lee has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Jason P. Fine
Department of Biostatistics University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
4 shared publicationsEric J. Feuer
Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland
3 shared publicationsBenjamin F. Hankey
Statistical Research and Application Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland
2 shared publications- Chang Wook Jeong
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
2 shared publications Il Do Ha
Department of Statistics, Pukyong National University, Busan, South Korea
2 shared publications- Soyeon Ahn
KAIST, Daejeon, Republic of Korea
2 shared publications
Latest Publications
- 1 July 2024
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 80 (3)
Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without augmented estimating equations
We estimate relative hazards and absolute risks (or cumulative incidence or crude risk) under cause-specific proportional hazards models for competing risks from double nested case-control (DNCC) data. In the DNCC design, controls are time-matched not only to cases from the cause of primary interest, but also to cases from competing risks (the phase-two sample). Complete covariate data are available in the phase-two sample, but other cohort members only have information on survival outcomes and some covariates. Design-weighted estimators use inverse sampling probabilities computed from Samuelsen-type calculations for DNCC. To take advantage of additional information available on all cohort members, we augment the estimating equations with a term that is unbiased for zero but improves the efficiency of estimates from the cause-specific proportional hazards model. We establish the asymptotic properties of the proposed estimators, including the estimator of absolute risk, and derive consistent variance estimators. We show that augmented design-weighted estimators are more efficient than design-weighted estimators. Through simulations, we show that the proposed asymptotic methods yield nominal operating characteristics in practical sample sizes. We illustrate the methods using prostate cancer mortality data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study of the National Cancer Institute.
- 1 July 2024
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 80 (3)
Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without augmented estimating equations
We estimate relative hazards and absolute risks (or cumulative incidence or crude risk) under cause-specific proportional hazards models for competing risks from double nested case-control (DNCC) data. In the DNCC design, controls are time-matched not only to cases from the cause of primary interest, but also to cases from competing risks (the phase-two sample). Complete covariate data are available in the phase-two sample, but other cohort members only have information on survival outcomes and some covariates. Design-weighted estimators use inverse sampling probabilities computed from Samuelsen-type calculations for DNCC. To take advantage of additional information available on all cohort members, we augment the estimating equations with a term that is unbiased for zero but improves the efficiency of estimates from the cause-specific proportional hazards model. We establish the asymptotic properties of the proposed estimators, including the estimator of absolute risk, and derive consistent variance estimators. We show that augmented design-weighted estimators are more efficient than design-weighted estimators. Through simulations, we show that the proposed asymptotic methods yield nominal operating characteristics in practical sample sizes. We illustrate the methods using prostate cancer mortality data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study of the National Cancer Institute.
- 3 March 2024
- Published by Taylor & Francis in Statistics
- Vol. 58 (2) , 383-406
Augmented inverse probability weighted estimation and prediction for cause-specific proportional hazards regression with missing covariates
- 3 March 2024
- Published by Taylor & Francis in Statistics
- Vol. 58 (2) , 383-406
Augmented inverse probability weighted estimation and prediction for cause-specific proportional hazards regression with missing covariates
- Open Access
- 10 July 2023
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 149 (11) , 993-1000
A New Personalized Oral Cancer Survival Calculator to Estimate Risk of Death From Both Oral Cancer and Other Causes
Importance: Standard cancer prognosis models typically do not include much specificity in characterizing competing illnesses or general health status when providing prognosis estimates, limiting their utility for individuals, who must consider their cancer in the context of their overall health. This is especially true for patients with oral cancer, who frequently have competing illnesses.Objective: To describe a statistical framework and accompanying new publicly available calculator that provides personalized estimates of the probability of a patient surviving or dying from cancer or other causes, using oral cancer as the first data set.Design, Setting, and Participants: The models used data from the Surveillance, Epidemiology, and End Results (SEER) 18 registry (2000 to 2011), SEER-Medicare linked files, and the National Health Interview Survey (NHIS) (1986 to 2009). Statistical methods developed to calculate natural life expectancy in the absence of the cancer, cancer-specific survival, and other-cause survival were applied to oral cancer data and internally validated with 10-fold cross-validation. Eligible participants were aged between 20 and 94 years with oral squamous cell carcinoma.Exposures: Histologically confirmed oral cancer, general health status, smoking, and selected serious comorbid conditions.Main Outcomes and Measures: Probabilities of surviving or dying from the cancer or from other causes, and life expectancy in the absence of the cancer.Results: A total of 22 392 patients with oral squamous cell carcinoma (13 544 male [60.5%]; 1476 Asian and Pacific Islander [6.7%]; 1792 Black [8.0%], 1589 Hispanic [7.2%], 17 300 White [78.1%]) and 402 626 NHIS interviewees were included in this calculator designed for public use for patients ages 20 to 86 years with newly diagnosed oral cancer to obtain estimates of health status–adjusted age, life expectancy in the absence of the cancer, and the probability of surviving, dying from the cancer, or dying from other causes within 1 to 10 years after diagnosis. The models in the calculator estimated that patients with oral cancer have a higher risk of death from other causes than their matched US population, and that this risk increases by stage.Conclusions and relevance: The models developed for the calculator demonstrate that survival estimates that exclude the effects of coexisting conditions can lead to underestimates or overestimates of survival. This new calculator approach will be broadly applicable for developing future prognostic models of cancer and noncancer aspects of a person’s health in other cancers; as registries develop more linkages, available covariates will become broader, strengthening future tools.
- 10 July 2023
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 149 (11) , 993-1000
Open AccessA New Personalized Oral Cancer Survival Calculator to Estimate Risk of Death From Both Oral Cancer and Other Causes
Importance: Standard cancer prognosis models typically do not include much specificity in characterizing competing illnesses or general health status when providing prognosis estimates, limiting their utility for individuals, who must consider their cancer in the context of their overall health. This is especially true for patients with oral cancer, who frequently have competing illnesses.Objective: To describe a statistical framework and accompanying new publicly available calculator that provides personalized estimates of the probability of a patient surviving or dying from cancer or other causes, using oral cancer as the first data set.Design, Setting, and Participants: The models used data from the Surveillance, Epidemiology, and End Results (SEER) 18 registry (2000 to 2011), SEER-Medicare linked files, and the National Health Interview Survey (NHIS) (1986 to 2009). Statistical methods developed to calculate natural life expectancy in the absence of the cancer, cancer-specific survival, and other-cause survival were applied to oral cancer data and internally validated with 10-fold cross-validation. Eligible participants were aged between 20 and 94 years with oral squamous cell carcinoma.Exposures: Histologically confirmed oral cancer, general health status, smoking, and selected serious comorbid conditions.Main Outcomes and Measures: Probabilities of surviving or dying from the cancer or from other causes, and life expectancy in the absence of the cancer.Results: A total of 22 392 patients with oral squamous cell carcinoma (13 544 male [60.5%]; 1476 Asian and Pacific Islander [6.7%]; 1792 Black [8.0%], 1589 Hispanic [7.2%], 17 300 White [78.1%]) and 402 626 NHIS interviewees were included in this calculator designed for public use for patients ages 20 to 86 years with newly diagnosed oral cancer to obtain estimates of health status–adjusted age, life expectancy in the absence of the cancer, and the probability of surviving, dying from the cancer, or dying from other causes within 1 to 10 years after diagnosis. The models in the calculator estimated that patients with oral cancer have a higher risk of death from other causes than their matched US population, and that this risk increases by stage.Conclusions and relevance: The models developed for the calculator demonstrate that survival estimates that exclude the effects of coexisting conditions can lead to underestimates or overestimates of survival. This new calculator approach will be broadly applicable for developing future prognostic models of cancer and noncancer aspects of a person’s health in other cancers; as registries develop more linkages, available covariates will become broader, strengthening future tools.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes
Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression. Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments. In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment. Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features. Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation. Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T-cell function following Tet2 depletion. Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.Significance:This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes
Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression. Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments. In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment. Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features. Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation. Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T-cell function following Tet2 depletion. Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.Significance:This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.
- 25 July 2022
- Published by Taylor & Francis in Journal of Statistical Computation and Simulation
- Vol. 92 (16) , 3301-3316
Semiparametric analysis of recurrent discrete time data with competing risks
The regression analysis of the cumulative incidence function on recurrent discrete time data with competing risks has not been widely investigated. We propose semiparametric analysis for regression modelling of the cumulative incidence function for recurrent discrete time competing risks data. The maximum likelihood inferences are developed for the estimation of the model parameters in a discrete time competing risks model, which are based on a working independence likelihood. We derive the sandwich variance estimator to account for correlations between multiple discrete times within each subject. Simulation studies show that the procedures perform well. The proposed methods are illustrated with two applications, a study of contraceptive use in Indonesia and data on unemployment in Germany.
- 25 July 2022
- Published by Taylor & Francis in Journal of Statistical Computation and Simulation
- Vol. 92 (16) , 3301-3316
Semiparametric analysis of recurrent discrete time data with competing risks
The regression analysis of the cumulative incidence function on recurrent discrete time data with competing risks has not been widely investigated. We propose semiparametric analysis for regression modelling of the cumulative incidence function for recurrent discrete time competing risks data. The maximum likelihood inferences are developed for the estimation of the model parameters in a discrete time competing risks model, which are based on a working independence likelihood. We derive the sandwich variance estimator to account for correlations between multiple discrete times within each subject. Simulation studies show that the procedures perform well. The proposed methods are illustrated with two applications, a study of contraceptive use in Indonesia and data on unemployment in Germany.
- 7 June 2022
- Published by Wiley in Statistics in Medicine
- Vol. 41 (20) , 3941-3957
Competing risks predictions with different time scales under the additive risk model
In the analysis for competing risks data, regression modeling of the cause‐specific hazard functions has been usually conducted using the same time scale for all event types. However, when the true time scale is different for each event type, it would be appropriate to specify regression models for the cause‐specific hazards on different time scales for different event types. Often, the proportional hazards model has been used for regression modeling of the cause‐specific hazard functions. However, the proportionality assumption may not be appropriate in practice. In this article, we consider the additive risk model as an alternative to the proportional hazards model. We propose predictions of the cumulative incidence functions under the cause‐specific additive risk models employing different time scales for different event types. We establish the consistency and asymptotic normality of the predicted cumulative incidence functions under the cause‐specific additive risk models specified on different time scales using empirical processes and derive consistent variance estimators of the predicted cumulative incidence functions. Through simulation studies, we show that the proposed prediction methods perform well. We illustrate the methods using stage III breast cancer data obtained from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute.
- 7 June 2022
- Published by Wiley in Statistics in Medicine
- Vol. 41 (20) , 3941-3957
Competing risks predictions with different time scales under the additive risk model
In the analysis for competing risks data, regression modeling of the cause‐specific hazard functions has been usually conducted using the same time scale for all event types. However, when the true time scale is different for each event type, it would be appropriate to specify regression models for the cause‐specific hazards on different time scales for different event types. Often, the proportional hazards model has been used for regression modeling of the cause‐specific hazard functions. However, the proportionality assumption may not be appropriate in practice. In this article, we consider the additive risk model as an alternative to the proportional hazards model. We propose predictions of the cumulative incidence functions under the cause‐specific additive risk models employing different time scales for different event types. We establish the consistency and asymptotic normality of the predicted cumulative incidence functions under the cause‐specific additive risk models specified on different time scales using empirical processes and derive consistent variance estimators of the predicted cumulative incidence functions. Through simulation studies, we show that the proposed prediction methods perform well. We illustrate the methods using stage III breast cancer data obtained from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute.
- Open Access
- 25 November 2021
- Published by The Japanese Society of Physical Fitness and Sports Medicine in The Journal of Physical Fitness and Sports Medicine
- Vol. 10 (6) , 298-316
Musculoskeletal system
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 25 November 2021
- Published by The Japanese Society of Physical Fitness and Sports Medicine in The Journal of Physical Fitness and Sports Medicine
- Vol. 10 (6) , 298-316
Open AccessMusculoskeletal system
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 28 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (29) , 5528-5546
Analyzing discrete competing risks data with partially overlapping or independent data sources and nonstandard sampling schemes, with application to cancer registries
This paper demonstrates the flexibility of a general approach for the analysis of discrete time competing risks data that can accommodate complex data structures, different time scales for different causes, and nonstandard sampling schemes. The data may involve a single data source where all individuals contribute to analyses of both cause‐specific hazard functions, overlapping datasets where some individuals contribute to the analysis of the cause‐specific hazard function of only one cause while other individuals contribute to analyses of both cause‐specific hazard functions, or separate data sources where each individual contributes to the analysis of the cause‐specific hazard function of only a single cause. The approach is modularized into estimation and prediction. For the estimation step, the parameters and the variance‐covariance matrix can be estimated using widely available software. The prediction step utilizes a generic program with plug‐in estimates from the estimation step. The approach is illustrated with three prognostic models for stage IV male oral cancer using different data structures. The first model uses only men with stage IV oral cancer from population‐based registry data. The second model strategically extends the cohort to improve the efficiency of the estimates. The third model improves the accuracy for those with a lower risk of other causes of death, by bringing in an independent data source collected under a complex sampling design with additional other‐cause covariates. These analyses represent novel extensions of existing methodology, broadly applicable for the development of prognostic models capturing both the cancer and noncancer aspects of a patient's health.
- 28 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (29) , 5528-5546
Analyzing discrete competing risks data with partially overlapping or independent data sources and nonstandard sampling schemes, with application to cancer registries
This paper demonstrates the flexibility of a general approach for the analysis of discrete time competing risks data that can accommodate complex data structures, different time scales for different causes, and nonstandard sampling schemes. The data may involve a single data source where all individuals contribute to analyses of both cause‐specific hazard functions, overlapping datasets where some individuals contribute to the analysis of the cause‐specific hazard function of only one cause while other individuals contribute to analyses of both cause‐specific hazard functions, or separate data sources where each individual contributes to the analysis of the cause‐specific hazard function of only a single cause. The approach is modularized into estimation and prediction. For the estimation step, the parameters and the variance‐covariance matrix can be estimated using widely available software. The prediction step utilizes a generic program with plug‐in estimates from the estimation step. The approach is illustrated with three prognostic models for stage IV male oral cancer using different data structures. The first model uses only men with stage IV oral cancer from population‐based registry data. The second model strategically extends the cohort to improve the efficiency of the estimates. The third model improves the accuracy for those with a lower risk of other causes of death, by bringing in an independent data source collected under a complex sampling design with additional other‐cause covariates. These analyses represent novel extensions of existing methodology, broadly applicable for the development of prognostic models capturing both the cancer and noncancer aspects of a patient's health.
- 9 February 2019
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 46 (12) , 2128-2144
Parametric inference for quantile event times with adjustment for covariates on competing risks data
We propose parametric inferences for quantile event times with adjustment for covariates on competing risks data. We develop parametric quantile inferences using parametric regression modeling of the cumulative incidence function from the cause-specific hazard and direct approaches. Maximum likelihood inferences are developed for estimation of the cumulative incidence function and quantiles. We develop the construction of parametric confidence intervals for quantiles. Simulation studies show that the proposed methods perform well. We illustrate the methods using early stage breast cancer data.
- 9 February 2019
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 46 (12) , 2128-2144
Parametric inference for quantile event times with adjustment for covariates on competing risks data
We propose parametric inferences for quantile event times with adjustment for covariates on competing risks data. We develop parametric quantile inferences using parametric regression modeling of the cumulative incidence function from the cause-specific hazard and direct approaches. Maximum likelihood inferences are developed for estimation of the cumulative incidence function and quantiles. We develop the construction of parametric confidence intervals for quantiles. Simulation studies show that the proposed methods perform well. We illustrate the methods using early stage breast cancer data.
- Open Access
- 1 December 2018
- Published by Elsevier in Prostate International
- Vol. 6 (4) , 140-144
Comparative quality-adjusted survival analysis between radiation therapy alone and radiation with androgen deprivation therapy in patients with locally advanced prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 85-31 with novel decision analysis methods
- 1 December 2018
- Published by Elsevier in Prostate International
- Vol. 6 (4) , 140-144
Open AccessComparative quality-adjusted survival analysis between radiation therapy alone and radiation with androgen deprivation therapy in patients with locally advanced prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 85-31 with novel decision analysis methods